<bill session="118" type="h" number="1393" updated="2024-07-03T08:05:28Z">
  <state datetime="2023-03-07">REFERRED</state>
  <status>
    <introduced datetime="2023-03-07"/>
  </status>
  <introduced datetime="2023-03-07"/>
  <titles>
    <title type="display">To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.</title>
    <title type="official" as="introduced">To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="D000631"/>
  <cosponsors>
    <cosponsor bioguide_id="A000376" joined="2024-03-08"/>
    <cosponsor bioguide_id="B001298" joined="2024-03-08"/>
    <cosponsor bioguide_id="B001307" joined="2024-07-02"/>
    <cosponsor bioguide_id="B000574" joined="2023-05-25"/>
    <cosponsor bioguide_id="C001130" joined="2023-06-23"/>
    <cosponsor bioguide_id="G000598" joined="2023-07-19"/>
    <cosponsor bioguide_id="J000032" joined="2024-07-02"/>
    <cosponsor bioguide_id="J000292" joined="2023-05-25"/>
    <cosponsor bioguide_id="K000389" joined="2023-07-19"/>
    <cosponsor bioguide_id="L000582" joined="2024-03-08"/>
    <cosponsor bioguide_id="L000603" joined="2023-06-23"/>
    <cosponsor bioguide_id="M000194" joined="2023-03-07"/>
    <cosponsor bioguide_id="M001215" joined="2023-07-19"/>
    <cosponsor bioguide_id="N000193" joined="2024-07-02"/>
    <cosponsor bioguide_id="T000460" joined="2024-03-08"/>
    <cosponsor bioguide_id="V000135" joined="2024-03-08"/>
    <cosponsor bioguide_id="W000822" joined="2024-07-02"/>
    <cosponsor bioguide_id="W000828" joined="2023-07-19"/>
  </cosponsors>
  <actions>
    <action datetime="2023-03-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-03-07" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-03-07">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-03-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="118" type="s" number="689" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
  </subjects>
  <amendments/>
  <summary date="2023-10-02T18:46:38Z" status="Introduced in House">This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)</summary>
</bill>
